Cargando…
Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-β/Smad Signaling Pathway
Hepatic fibrosis occurs when liver tissue becomes scarred from repetitive liver injury and inflammatory responses; it can progress to cirrhosis and eventually to hepatocellular carcinoma. Previously, we reported that neoagarooligosaccharides (NAOs), produced by the hydrolysis of agar by β-agarases,...
Autores principales: | Yang, Ji Hye, Ku, Sae Kwang, Cho, IL Je, Lee, Je Hyeon, Na, Chang-Su, Ki, Sung Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922480/ https://www.ncbi.nlm.nih.gov/pubmed/33670808 http://dx.doi.org/10.3390/ijms22042041 |
Ejemplares similares
-
Anti-Obesity and Anti-Diabetic Effect of Neoagarooligosaccharides on High-Fat Diet-Induced Obesity in Mice
por: Hong, Sun Joo, et al.
Publicado: (2017) -
Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis
por: Ki, Sung Hwan, et al.
Publicado: (2013) -
Dendropanax morbifera Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways
por: Yang, Hun Yong, et al.
Publicado: (2019) -
Different Levels of Skin Whitening Activity among 3,6-Anhydro-l-galactose, Agarooligosaccharides, and Neoagarooligosaccharides
por: Kim, Ji Hye, et al.
Publicado: (2017) -
Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation
por: Azamov, Bakhovuddin, et al.
Publicado: (2023)